GlassScriptPhysician profile
William Skelton
NPI 1962880880
$6,477.20
in general payments reported to CMS, 2019-2025
12 companies · $644 in 2025
The $644 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $209 · 2021: $549 · 2022: $165 · 2023: $269 · 2024: $4,300 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,978 · Food and Beverage: $1,778 · Travel and Lodging: $1,444 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,977.50 |
| Food and Beverage | $1,778.25 |
| Travel and Lodging | $1,444.45 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $4,938.43 | 2021-2025 | Cabometyx |
| Janssen Biotech, INC. | $402.15 | 2019-2022 | |
| Pfizer INC. | $232.08 | 2024-2025 | |
| Incyte Corporation | $185.49 | 2021-2022 | |
| Tempus Ai, INC | $145.74 | 2024 | Xt Cdx |
| Celgene Corporation | $124.38 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $123.61 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $117.02 | 2021 | |
| Astellas Pharma US INC | $99.95 | 2019 | |
| Seagen INC. | $95.00 | 2021 | |
| Eisai INC. | $13.35 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Skelton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.